PRODUCTS
ALL A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
 |
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
 |
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
| Mirabegron Extended-Release Tablets | 25mg |
|
30 |
68180-151-06 |
Myrbetriq® |
AB |
Beta-3 Adrenergic Agonist |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
